Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Alto Neuroscience (NYSE:ANRO) Q3 Loss Per Share of USD 0.54 Is Narrower Than Estimate as Phase 2b Spending Grows

Research and development expense was USD 18.2 million against USD 10.5 million, and general and administrative expense was USD 9.1 million against USD 4.4 million. The filing attributes about USD 6.9 million of the research increase to development of ALTO-207, which the company acquired …

Nitish Kishor | 12 November 2026

Ampco-Pittsburgh (NYSE:AP) Q3 Earnings of USD 0.02 Per Share Follow Sales Growth of 17%

Management said third quarter revenue increased 17% from the prior year and year to date revenue increased 12%. The nine month net income attributable to the company was USD 1,080,000, or USD 0.05 per share, and the filing states that this figure includes a …

Nitish Kishor | 12 November 2026

Alpha Pro Tech (NYSE American:APT) Q3 Earnings of USD 0.19 Per Share Double Prior Year on Sales of USD 16.6 Million

Gross profit increased by USD 1,069,000, or 18.2%, to USD 6,937,000. TheGross Profitmargin was 41.8% against 39.7% a year earlier. Income from operations was USD 1,970,000 against USD 1,097,000.

Nitish Kishor | 12 November 2026

Anterix (NASDAQ:ATEX) Fiscal Q2 Loss Per Share Is Narrower Than Estimate With USD 107.5 Million in Cash

The filing states spectrum revenue rose USD 0.4 million, or 26%, to USD 2.0 million. Management saidGAAPrevenue was about USD 2 million and operating expenses were about USD 9.4 million, and the company also recorded a USD 6.1 million gain on license exchanges in …

Nitish Kishor | 12 November 2026

Atossa Therapeutics (NASDAQ:ATOS) Q3 Loss of USD 0.56 Per Share Beats Estimate; Filing Cites Going Concern Doubt

The accumulatedDeficitwas USD 270.3 million. Cash and cash equivalents were USD 20.6 million at September 30, withWorking Capitalof USD 20.5 million.

Nitish Kishor | 12 November 2026

Atara Biotherapeutics (NASDAQ:ATRA) Q3 Revenue Tops Estimate While Going Concern Note and Class Action Remain Disclosed

For the nine months, the company reported a net loss of USD 11.2 million againstNet Incomeof USD 36.1 million in the prior-year period. The filing states commercialization revenue in the current period relates solely to ongoing regulatory activities and clinical vial sales, resulting in …

Nitish Kishor | 12 November 2026

Astronics Corporation (NASDAQ:ATRO) Reports Q3 Sales of USD 272 Million, Up 28.5%, and Maintains 2026 Revenue Guidance

Gross profit increased 46% to USD 94 million, or 34.6% of sales. Operating income doubled to a record USD 54 million, or 19.9% of sales, and adjusted operating income was USD 51 million.

Nitish Kishor | 12 November 2026

What Aviat Networks (NASDAQ:AVNW) Reported for Fiscal Q1 2027: Bookings Up 75%, Earnings Short

Adjusted EBITDA was USD 6.0 million, or 5.9% of revenue. GrossMarginwas 29.6% on both a GAAP and non-GAAP basis. GAAP operating expenses were USD 29.3 million, and non-GAAP operating expenses were USD 26.2 million.

Nitish Kishor | 12 November 2026

Anteris Technologies Global (NASDAQ:AVR) Q3 Loss of USD 0.28 Per Share Is Narrower Than Estimate With USD 236.3 Million in Cash

For the nine months, net loss was USD 78.50 million against USD 65.20 million, and loss per share was USD 0.85 against USD 1.80.

Nitish Kishor | 12 November 2026

A2Z Cust2Mate Solutions (NASDAQ:AZ) Reports Q3 Revenue of USD 10.9 Million as Smart Cart Deliveries Double

Management said total revenues increased to USD 10.9 million, of which smart cart revenues more than doubled sequentially to USD 9.6 million, reflecting growing deliveries across multiple customers. Third quarter net loss was USD 6.6 million, or USD 0.15 per share, compared with a …

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…